USPTO serial 88884168
ASCENDIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 25, 2023
- Examiner
- CLARK, MICHAEL J.
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ASCENDIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shannon Marie McKeon
Shannon Marie McKeon DYKEMA GOSSETT PLLC1301 K STR., N.W., SUITE 1100WASHINGTON, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the treatment of physical and mental diseases; Pharmaceutical and medical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer and infectious diseases; Diagnostic preparations for medicinal use; Diagnostic preparations for identification and proof of physical and mental diseases; Diagnostic preparations for identifying and detecting growth hormone disorders, endocrine disorders, bone disorders and cancer and infectious diseases; Dietetic preparations for medical use, sanitary preparations for medical use, dietetic preparations adapted for medical use, food supplements; Medicated shampoos, soaps, lotions for skin, face and body and dentifrices; Disinfectants; Fungicides, herbicides | ACTIVE | — |
| 009 | Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to physical and mental diseases fur use by patients and health care professional; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history | ACTIVE | — |
| 010 | Medical devices for injection, dosage and control of pharmaceuticals; Syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the treatment of physical and mental diseases; Medical apparatus, namely, infusion and injection devices for administering drugs; Medicine dosage dispensers containing recorded software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; medicine dosage management dispensers containing recorded software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic | ACTIVE | — |
| 041 | Educational and teaching services, namely, training sessions and providing classes, workshops, and seminars in the field of pharmaceutical, medical, and health care topics; Arranging and conducting of conferences, including speaker programs, symposiums, seminars, workshops, lectures and online education seminars and guides about pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Non-downloadable electronic publications in the nature of ad boards, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Similar marks named ASCENDIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 3, 2023 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 27, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 27, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 27, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 27, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 27, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 26, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 26, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 6, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 15, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 14, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 14, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 14, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 29, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 2, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 2, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 2, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 2, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 27, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 27, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 27, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2020 | NWAP | NEW APPLICATION ENTERED | — |